Medtech Solutions

• Throughout the forecast period, growth in the Japanese heart valve device will be driven by rapid adoption of THV devices, which command higher prices than surgical valves and will significantly expand the treatable population
• Although TAVR devices are the only THV devices currently available in Japan, other products, such as TMVR devices, will enter the market during this forecast period
• In the heart valve replacement device market, TAVR procedures will cannibalize surgical procedures because clinical results have been positive for TAVR in high-risk surgical patients

• In the Middle East, the very high prevalence of obesity as well as the relatively wealthy population in this region will drive strong growth in the market for obesity interventions through 2026
• Although Egypt and Turkey both have very large populations Saudi Arabia and Israel had the largest markets for obesity interventions in the Middle East in 2017
• Kuwait has the highest obesity intervention penetration rate among the Middle Eastern countries covered despite having the least number of obese patients, which stems from the small size of the country’s total population

Download report

• The global powered surgical instrument market is fairly mature, with growth largely driven by favorable demographics that will increase the incidence of conditions requiring surgical interventions, many of which involve the use of powered surgical instruments
• The US market for powered surgical instruments accounted for approximately 75% of global revenues in 2016 and is expected to reach a value of more than $1.1 billion by 2025
• Over the forecast period, global powered surgical instrument market growth will be fueled by favorable demographics, namely the global expansion of the over 65 year demographic and the obese population

• The European market for urological devices will experience minimal growth throughout the forecast period; this growth is mainly attributed to ongoing product innovation and an aging population
• On the other hand, the market for prostate cancer treatment devices will exhibit heavy declines due to evolving treatment recommendations as well as lingering budgetary constraints over the purchase of capital equipment throughout the region
• Within the European market for urological devices, the urinary catheter segment continues to represent a significant portion of the overall market

• The US advanced visualization system market is being negatively impacted by a number of headwinds that will cause declines in unit sales over the course of the forecast period
• The advanced visualization system market is notably affected by trends in the diagnostic imaging market
• Nonetheless, the health care needs of an aging and ailing US population will help support ASPs for advanced visualization tools, particularly in radiology, oncology, and cardiology through 2025